SGS’s Shanghai Health Science Laboratory completes US FDA inspection with zero 483 observations
- Thursday, October 3, 2024, 7:13
- Top Stories
- Add a comment
SGS has set a new benchmark for third-party pharmaceutical testing laboratories in China following an outstanding inspection by the US FDA of the company’s Shanghai Health Science Laboratory.
About the Author
admin has written 20523 stories on this site.